Discordant Biomarkers Foretell Prognosis in Oropharyngeal Cancer
Mismatch between the p16 protein and human papillomavirus (HPV) biomarkers can help determine prognosis in patients with oropharyngeal cancer, European researchers reported. Specifically, oropharyngeal cancer patients with discordance between the p16 (p16INK4a ) and HPV biomarker had significantly worse disease-free survival (DFS) and overall survival (OS) than double-positive patients, though significantly better survival than double-negative […]